16957-97-4

Upstream product

• 95-15-8 Benzo[b]thiophene 
• 7342-82-7 3-Bromothianaphthene 
• 6345-55-7 5-nitrobenzo[b]thiophene-2-carboxylic acid 
• 19492-95-6 3-bromo-5-nitrobenzo[b]thiophene 
• 4965-26-8 5-nitrobenzo[b]thiophene 
• 98434-36-7 3-bromo-benzo[b]thiophen-5-ylamine 

Downstream Products

• 461437-53-6 3-((5-(p-tolyl)-1,3,4-oxadiazol-2-yl)thio)benzo[b]thiophene 1,1-dioxide 
• 1022-19-1 3-piperidinobenzothiophene S,S-dioxide 

Relevant academic research and scientific papers

Synthesis of 3-Benzo[b]thienyl 3-Thienyl Ether via an Addition-Elimination Reaction and Its Transformation to an Oxygen-Fused Dithiophene Skeleton: Synthesis and Properties of Benzodithienofuran and Its π-Extended Derivatives

The synthesis of 3-benzo[b]thienyl 3-thienyl ether and its dehydrogenative cyclization leading to benzodithienofuran (BDTF; [1]benzothieno[3,2-b]thieno[2,3-d]furan) are described for the first time. Further transformation of BDTF to more π-extended BDTF d

Bis(diphenylamino)-benzo[4,5]thieno[3,2-b]benzofuran as hole transport material for highly efficient RGB organic light-emitting diodes with low efficiency roll-off and long lifetime

In this work, a novel hole transport material (HTM) based on benzo[4,5]thieno[3,2-b]benzofuran (BTBF) core with diphenylamine group, BTBF-DPA, was synthesized and systematically studied. BTBF-DPA showed high carrier mobility, good thermal stability and high triplet energy as 2.99 eV. Green phosphorescent organic light-emitting diodes (PhOLEDs) using BTBF-DPA were fabricated which displayed outstanding electroluminescent performance with a low turn-on voltage of 2.4 V, the maximum current efficiency (CE) of 123.6 cd A?1, power efficiency (PE) of 136.6 lm W?1, and external quantum efficiency (EQE) of 34.1%. Red PhOLEDs with BTBF-DPA also demonstrated a maximum PE of 40.1 lm W?1, and EQE of 24.9% with a low turn-on voltage of 2.3 V. Besides, blue fluorescence OLEDs presented a maximum PE of 4.9 lm W?1, EQE of 5.2% and small efficiency roll-off of 11.5% at 10000 cd m?2. RGB-OLEDs with BTBF-DPA outperformed the reference devices based on NPB as HTM that has been widely utilized. What's more, life-time of RGB OLEDs were T99 = 70 h at 10000 cd m?2, T70 = 60 h at 10000 cd m?2, T80 = 125 h at 5000 cd m?2, respectively. These results imply that BTBF-DPA is a promising HTM for OLEDs.

Preparation method and medical application of benzisothiazole and benzothiophene

The invention discloses a preparation method and medical application of benzisothiazole and benzothiophene, and telates to the field of pharmaceutical chemistry. According to the invention, benzisothiazole and benzothiophene are the first type of HIF-2 agonists; compared with a compound M1001 found by the applicant in the earlier stage, the invention has better HIF-2 agonist activity, and has remarkable enhancement activity on expression of mRNA and protein of EPO, VGEF, Glut1, NDRG1 and the like at the downstream of HIF-2, so that the invention can be used for preparing drugs for treating and/or preventing chronic kidney diseases/chronic renal anemia, dyslipidemia and high cholesterol caused by abnormal expression of HIF-2; and the method has a good industrialization prospect.

Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia

Activation of hypoxia-inducible factor 2 (HIF-2) has emerged as a potent renal anemia treatment strategy. Here, the benzisothiazole derivative 26 was discovered as a novel HIF-2α agonist, which first demonstrated nanomolar activity (EC50 = 490 nM, Emax = 349.2%) in the luciferase reporter gene assay. Molecular dynamics simulations indicated that 26 could allosterically enhance HIF-2 dimerization. Furthermore, compound 26 had a good pharmacokinetic profile (the oral bioavailability in rats was 41.38%) and an in vivo safety profile (the LD50 in mice was greater than 708 mg·kg-1). In the in vivo efficacy assays, the combination of 26 and the prolyl hydroxylase inhibitor, AKB-6548, was confirmed for the first time to synergistically increase the plasma erythropoietin level in mice (from 260 to 2296 pg·mL-1) and alleviate zebrafish anemia induced by doxorubicin. These results provide new insights for HIF-2α agonists and the treatment of renal anemia.

Diels-Alder reaction of tetraarylcyclopentadienones with benzo[: B] thiophene S, S-dioxides: An unprecedented de-oxygenation vs. sulfur dioxide extrusion

Diels-Alder reaction of tetraarylcyclopentadienones with benzo[b]thiophene dioxides in xylenes at reflux led to the formation of tetra aryl-substituted dibenzothiophene as well as penta aryl-substituted benzene analogues depending on the influence of aryl substituents present on cyclopentadienones. The intermediate dihydrodibenzothiophene-dioxides underwent aromatization either through de-oxygenation or extrusion of sulfur dioxide to furnish substituted dibenzothiophenes or benzenes. This journal is

Synthesis of Polysubstituted Iodoarenes Enabled by Iterative Iodine-Directed para and ortho C?H Functionalization

Among halogenated aromatics, iodoarenes are unique in their ability to produce the bench-stable halogen(III) form. Earlier, such iodine(III) centers were shown to enable C?H functionalization ortho to iodine via halogen-centered rearrangement. The broader implications of this phenomenon are explored by testing the extent of an unusual iodane-directed para C?H benzylation, as well as by developing an efficient C?H coupling with sulfonyl-substituted allylic silanes. Through the combination of the one-shot nature of the coupling event and the iodine retention, multisubstituted arenes can be prepared by sequentially engaging up to three aromatic C?H sites. This type of iodine-based iterative synthesis will serve as a tool for the formation of value-added aromatic cores.

Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles

Fungi cause serious life-threatening infections in immunocompromised individuals and current treatments are now complicated by toxicity issues and the emergence of drug resistant strains. Consequently, there is a need for development of new antifungal drugs. Inosine monophosphate dehydrogenase (IMPDH), a key component of the de novo purine biosynthetic pathway, is essential for growth and virulence of fungi and is a potential drug target. In this study, a high-throughput screen of 114,000 drug-like compounds against Cryptococcus neoformans IMPDH was performed. We identified three 3-((5-substituted)-1,3,4-oxadiazol-2-yl)thio benzo[b]thiophene 1,1-dioxides that inhibited Cryptococcus IMPDH and also possessed whole cell antifungal activity. Analogs were synthesized to explore the SAR of these hits. Modification of the fifth substituent on the 1,3,4-oxadiazole ring yielded compounds with nanomolar in vitro activity, but with associated cytotoxicity. In contrast, two analogs generated by substituting the 1,3,4-oxadiazole ring with imidazole and 1,2,4-triazole gave reduced IMPDH inhibition in vitro, but were not cytotoxic. During enzyme kinetic studies in the presence of DTT, nucleophilic attack of a free thiol occurred with the benzo[b]thiophene 1,1-dioxide. Two representative compounds with substitution at the 5 position of the 1,3,4-oxadiazole ring, showed mixed inhibition in the absence of DTT. Incubation of these compounds with Cryptococcus IMPDH followed by mass spectrometry analysis showed non-specific and covalent binding with IMPDH at multiple cysteine residues. These results support recent reports that the benzo[b]thiophene 1,1-dioxides moiety as PAINS (pan-assay interference compounds) contributor.

ORGANIC SEMICONDUCTING COMPOUNDS

The invention relates to novel organic semiconducting compounds, which are small molecules or conjugated polymers, containing one or more isoindigo or thienoisoindigo based polycyclic units, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to the use of the compounds, compositions and polymer blends as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, organic photodetectors (OPD), Perovskite based solar cells, organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, OPD, OFET and OLED devices comprising these compounds, compositions or polymer blends.